Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Detailed Brain Imaging Study to Help Unlock Root Causes of Dementia

Published: Thursday, May 22, 2014
Last Updated: Thursday, May 22, 2014
Bookmark and Share
Large population scanning heralds a new era in research to tackle dementia and a wide range of intractable diseases.

Having enlisted thousands of Britons and captured detailed information about their health and lifestyle, UK Biobank is now turning its attention to their brains – as part of the global effort to defeat dementia. Around 100,000 participants are expected to be part of the world’s most comprehensive imaging project over the next five years, following the launch of a feasibility study.

The pilot phase of the programme has just been initiated and the first 50 subjects have already been successfully scanned using advanced magnetic resonance imaging (MRI) technology from Siemens Healthcare. The study will capture images not only of their brains, but also their hearts and other organs in the quest to unlock understanding into the causes of dementia and diseases of middle to older age.  

With the focus on Dementia Awareness Week – 18 to 24 May 2014 – making headlines, and the six month anniversary of the government announcing the doubling of research funding for dementia by 20251, excitement is mounting about the potential of this new research.

Non-invasive brain scans of UK Biobank participants, now aged 44-77, are being captured using high-end Siemens medical imaging technology. Data from cognitive testing, a range of physical evaluations, DNA and health records are also being included in this mammoth project. By 2022 UK Biobank expects to have captured about 9,000 cases of Alzheimer’s disease, due to the natural ageing of the UK Biobank population. Combining such data is creating a huge health research resource, one of the largest in the world, for use by bona fide scientists anywhere in the world.

UK Biobank’s vast data resource is now open. It is being updated and added to all the time. The promise of high quality images of brain, heart, blood supply and bones in addition to this data will change the face of health research, the project believes. It will galvanise new ways of looking at data, as well as help scientists at the coal face trying to identify key causes of disease and ways to prevent and better treat them.

Professor Paul Matthews, Head of the Division of Brain Sciences at Imperial College, London, who led the experts that developed the UK Biobank imaging plans, states, “Development of treatments to slow or stop dementia is the greatest healthcare challenge facing the developed world. New clues suggest that we need to broaden our research focus on the brain in the context of the whole body and the way it changes with age to find the triggers for Alzheimer’s and vascular dementia. We need to study people before and in the earliest stages to confirm mechanisms and test new drugs. UK Biobank will provide an unrivalled resource for these studies with the addition of advanced brain and body imaging to its rich clinical, cognitive, soluble biomarker and genetic dataset. This ambitious programme promises to massively accelerate both public and private therapeutics research for dementia.”

He adds, “Commitment by the Medical Research Council to fund the UK Biobank imaging feasibility study is a shot in the arm to dementia research – and the research community will work together to put this tool to best use.”

Craig Buckley, Head of Research and Scientific Collaborations at Siemens Healthcare GB&I states, “With a growing ageing population and diagnosed dementia rates on the rise, the race is on to fully characterise the disease. With the help of imaging, we hope to be able to slow the pace, prevent and even cure these syndromes. To date, dementia research has faced great challenges, with limited access to large scale, standardised brain data to help with understanding of the disease. With increasing support from government bodies, research institutions such as UK Biobank can now access cutting-edge imaging technology to ensure every scan is consistent for each participant, helping to create a new wave of data that is more accurate and insightful than ever before.”

At the end of 2013, governments of the G8 countries turned their attention to dementia research, committing to more funding to source better treatments and diagnosis tools for the 800,000 people living with dementia in the UK. It is believed delaying the onset of dementia by five years would reduce deaths dramatically2. UK Biobank has been recognised as a key support tool, with support received from UK governments, the Wellcome Trust, Medical Research Council and British Heart Foundation.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Siemens Awarded Process Gas Chromatography Agreement by Shell
The agreement will see Siemens Industry Automation Division deliver process gas chromatographs to Shell For five years.
Friday, April 20, 2012
SIEMENS RECEIVES ORDER FROM RICH’S TO INITIATE INTEGRATED WATER & ENERGY SUSTAINABILITY PLATFORM
Rich Products Corporation orders Siemens’ integrated water & energy sustainability program todevelop a comprehensive understanding of the energy and water usage throughout their operations.
Sunday, April 08, 2012
Siemens to Emphasize Emerging Fields of Oncology, Neurology Biomarkers with New Research Facility
Siemens’ Molecular Imaging research facility is dedicated to the development of molecular imaging biomarkers for identifying debilitating diseases at their earliest stages.
Friday, February 09, 2007
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!